A simple and effective method for reconstruction of perioral defects: the transverse V-Y advancement flap


EUROPEAN JOURNAL OF PLASTIC SURGERY, 2021 (Journal Indexed in ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume:
  • Publication Date: 2021
  • Doi Number: 10.1007/s00238-021-01871-9
  • Keywords: Perioral defect, Lower lip, Upper lip, V-Y advancement flap, Reconstruction, Skin cancer, NORMAL RANGE, LIP


Background The perioral region is the most important area for facial expression, after the periocular structures. For the reconstructions of this region, an aesthetic outcome is as important as functional results in terms of the patient's social life. The purpose of this study was to discuss the functional and aesthetic outcomes achieved with transversely advanced V-Y flaps in reconstructions of the perioral region. Methods The study included 17 patients in whom transverse V-Y advancement flaps were used to repair full-thickness perioral defects resulting from malignant tumor resection. The patients were evaluated in terms of functional and aesthetic outcomes, complications, and need for revision surgery. To evaluate postoperative outcomes, a control group with no history of surgical interventions to the lips or perioral region was selected. Measurements of the lower and upper lips, mouth opening height, and mouth opening width were obtained from the controls and postoperatively from the patients. Results Lower lip reconstruction was performed in 13 patients (76.4%) and upper lip reconstruction was performed in 4 patients (23.5%). Total lower lip reconstruction was performed in 3 patients. Postoperative measurements were statistically equivalent to those of individuals with no surgical history. No cosmetic deformity formation or microstomia which require surgical treatment were observed in any of our patients. Conclusions This technique is a simple, useful, functional method with short procedure time and satisfying aesthetic outcomes for patients with total or partial lower and upper lip defects. Level of evidence: Level IV, therapeutic study.